Lupin rises as its arm launches first ever Duloxetine 40mg delayed-release Capsules in US

04 Sep 2015 Evaluate

Lupin is currently trading at Rs. 1867.20, up by 4.10 points or 0.22% from its previous closing of Rs. 1863.10 on the BSE.

The scrip opened at Rs. 1873.00 and has touched a high and low of Rs. 1882.00 and Rs. 1865.80 respectively. So far 8,738 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2112.00 on 08-Apr-2015 and a 52 week low of Rs. 1307.10 on 16-Oct-2014.

Last one week high and low of the scrip stood at Rs. 1938.85 and Rs. 1851.10 respectively. The current market cap of the company is Rs. 84,075.00 crore.

The promoters holding in the company stood at 46.59% while Institutions and Non-Institutions held 43.57% and 9.84% respectively.

Lupin Pharmaceuticals, a subsidiary of Lupin, has launched its Duloxetine 40 mg Delayed-Release (DR) Capsule, which is the first and only generic Duloxetine formulation to become available in 40 mg dosage strength. Lupin is excited to bring this new strength to market, as it adds to the currently-available dosing options for greater flexibility of treatment.

Lupin is the only generic manufacturer to offer all Duloxetine dosage strengths - the 20 mg, 30 mg, 60 mg, and now the newest 40 mg. Lupin’s generic Duloxetine 40 mg DR capsules are therefore the first and only capsule available for patients in this dosage strength.  Cymbalta Delayed-Release Capsules 20 mg, 30 mg and 60 mg strengths had annual U.S sales of approximately USD 1.05 billion (Brand + Generics - IMS MAT June 2015).

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations as well as biotechnology products and APIs globally.


Lupin Share Price

2151.05 19.25 (0.90%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×